[AMRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
07-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 98.02%
YoY- 43.59%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 599,046 557,540 609,759 545,557 559,355 497,633 536,896 7.59%
PBT 29,660 -9,426 -7,655 2,180 -232,731 -9,921 -16,319 -
Tax -23 668 -1,797 4,570 7,350 -3,461 4,140 -
NP 11,917 -10,094 -5,858 -2,390 -120,808 -6,460 -6,377 -
Tax Rate 0.08% - - -209.63% - - - -
Total Cost 587,129 567,634 615,617 547,947 680,163 504,093 543,273 5.32%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 1.99 -1.81 -0.96 -0.44 -21.60 -1.30 -1.19 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS 0.08 -0.07 -0.04 -0.02 -0.80 -0.04 -0.04 -
EPS Diluted 0.08 -0.07 -0.04 -0.02 -0.80 -0.04 -0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.